Results 81 to 90 of about 9,221 (233)

Human epididymis protein 4 (HE4) in benign and malignant diseases [PDF]

open access: yes, 2012
Background: Human epididymis protein 4 (HE4) is described as a useful new biomarker in ovarian cancer. As HE4 is neither tumor nor organ specific, we intensively investigated the occurrence of this protein in female and male patients with various benign ...
Anastasi   +39 more
core   +1 more source

Imaging in gynecological disease (28): clinical and ultrasound characteristics of serous and mucinous cystadenomas in the adnexa

open access: yesUltrasound in Obstetrics &Gynecology, Volume 66, Issue 2, Page 233-241, August 2025.
ABSTRACT Objective To describe the clinical and ultrasound characteristics of serous and mucinous cystadenomas in the adnexa. Methods This was a retrospective international multicenter study. Using the International Ovarian Tumor Analysis (IOTA) database, patients with a histological diagnosis of serous or mucinous cystadenoma who had undergone ...
F. Mascilini   +20 more
wiley   +1 more source

Differentiation of mucinous from non-mucinous pancreatic cyst fluid using dual-stained, 1 dimensional polyacrylamide gel electrophoresis [PDF]

open access: yes, 2014
BACKGROUND: Pancreatic cysts are being increasingly identified in patients. Mucinous cysts have malignant potential whereas non-mucinous cysts do not.
John C Deutsch   +5 more
core   +1 more source

The Ultrasonography Characteristics of Borderline Ovarian Tumor Subtypes

open access: yes
Journal of Ultrasound in Medicine, Volume 44, Issue 11, Page 2133-2146, November 2025.
Roni Yoeli‐Bik   +6 more
wiley   +1 more source

Primary hyperparathyroidism in a domestic shorthair cat following I131 radioiodine therapy

open access: yesJournal of Small Animal Practice, Volume 66, Issue 8, Page 582-586, August 2025.
A 12‐year‐old male neutered domestic shorthaired cat presented for further assessment of a cervical mass, having undergone radioiodine therapy for treatment of hyperthyroidism 2 years prior to presentation. Initial cytological diagnosis of the mass was supportive of a carcinoma and laboratory results were consistent with primary hyperparathyroidism ...
E. Ruane   +3 more
wiley   +1 more source

Cell‐free and extracellular vesicle microRNAs with clinical utility for solid tumors

open access: yesMolecular Oncology, Volume 19, Issue 7, Page 1935-1967, July 2025.
Cell‐free microRNAs (cfmiRs) are small‐RNA circulating molecules detectable in almost all body biofluids. Innovative technologies have improved the application of cfmiRs to oncology, with a focus on clinical needs for different solid tumors, but with emphasis on diagnosis, prognosis, cancer recurrence, as well as treatment monitoring.
Yoshinori Hayashi   +6 more
wiley   +1 more source

Discrimination of Pancreatic Serous Cystadenomas From Mucinous Cystadenomas With CT Textural Features: Based on Machine Learning

open access: yesFrontiers in Oncology, 2019
Objectives: This study was designed to estimate the performance of textural features derived from contrast-enhanced CT in the differential diagnosis of pancreatic serous cystadenomas and pancreatic mucinous cystadenomas.Methods: Fifty-three patients with
Jing Yang   +4 more
doaj   +1 more source

The Diagnostic Accuracy of Abdominal Ultrasound Imaging for Detection of Ovarian Masses [PDF]

open access: yes
Background/Objective: Detection of the tissue diagnosis of ovarian space occupying lesions (OSOL) has remained a challenging task for sonographers since many adnexal masses have nonspecific sonographic appearances.
رفاهی, سهیلا   +2 more
core  

Resected serous cystic neoplasms of the pancreas: Locally aggressive behavior as a predictor of malignant disease? A review of 158 patients with recommendations for treatment. [PDF]

open access: yes, 2007
Background: Serous cystic neoplasms of the pancreas are regarded as a benign entity with rare malignant potential. Surgical resection is generally considered curative.
Cameron, John L.   +8 more
core   +1 more source

Spatially resolved proteomics surveys the chemo‐refractory proteins related to high‐grade serous ovarian cancer

open access: yesClinical and Translational Medicine, Volume 15, Issue 7, July 2025.
HGSC intra‐tumour heterogeneity is predominantly driven by stroma, as revealed by spatial proteomic compartmentalization (tumour/stroma). Spatial proteomics expands the therapeutic target database, enabling prediction of platinum‐based chemotherapy response.
Linyuan Fan   +17 more
wiley   +1 more source

Home - About - Disclaimer - Privacy